Inflammatory Markers and Cognitive Performance in Patients With Schizophrenia Treated With Lurasidone

被引：0
作者：
Miller, Brian [1 ]
Pikalov, Andrei [1 ]
Siu, Cynthia [1 ]
Tocco, Michael [1 ]
Tsai, Joyce [1 ]
Harvey, Philip [1 ]
Loebel, Antony [1 ]
机构：
[1] Sunov Pharmaceut Inc, Ft Lee, NJ USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2017年 / 42卷
关键词：
Inflammatory Markers; Cognitive Functioning; Lurasidone; Lipids; Schizophrenia; Functional Capacity; Antipsychotic Treatment;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
W172
引用
收藏
页码：S585 / S585
页数：1
相关论文
共 50 条
  • [31] A Subset of Olfactory Neurons Derived From Schizophrenia Patients Exhibit Increased Markers for Protein Aggregation And Reduced Cognitive Performance
    Nucifora, Leslie
    Ishizuka, Koko Ishizuka
    Yenokyan, Gayane
    Cascella, Nicola
    Schretlen, David
    Harvey, Philip
    Ross, Christopher
    Margolis, Russell
    Sawa, Akira
    Nucifora, Frederick
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 342 - 342
  • [32] The relationship between peripheral immune cell markers and cognitive functions in patients with schizophrenia
    Karahan, Aykut
    Saka, Isilay Manzak
    Aykut, Demet Saglam
    Arslan, Filiz Civil
    Ozmen, Ezgi Selcuk
    Karaguzel, Evrim Ozkorumak
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE, 2024,
  • [33] Real-world treatment patterns and outcomes in patients initiating lurasidone for the treatment of schizophrenia in Europe
    Jones, A.
    Sargeant, M.
    Andiappan, M.
    EUROPEAN PSYCHIATRY, 2022, 65 : S205 - S205
  • [34] Hospitalization outcomes in patients with schizophrenia after switching to lurasidone or quetiapine: a US claims database analysis
    Newcomer, John W.
    Ng-Mak, Daisy
    Rajagopalan, Krithika
    Loebel, Antony
    BMC HEALTH SERVICES RESEARCH, 2018, 18
  • [35] Towards full recovery with lurasidone: effective doses in the treatment of agitation, affective, positive, and cognitive symptoms in schizophrenia and of dual psychosis
    Carreras, Maria Teresa Guarro
    Suarez, Luis Jimenez
    Garcia, Laura Lago
    Reula, Laura Montes
    del Rosari, Adrian Neyra
    Batista, Francisco Acoidan Rodriguez
    Santos, Miguel Velasco
    Prados-Ojeda, Juan L.
    Diaz-Marsa, Marina
    Martin-Carrasco, Manuel
    Cardenas, Antonio
    DRUGS IN CONTEXT, 2024, 13
  • [36] A Subset of Olfactory Neurons Derived From Schizophrenia Patients Exhibit Increased Markers for Protein Aggregation And Reduced Cognitive Performance
    Nucifora, Leslie
    Ishizuka, Koko Ishizuka
    Yenokyan, Gayane
    Cascella, Nicola
    Schretlen, David
    Harvey, Philip
    Ross, Christopher
    Margolis, Russell
    Sawa, Akira
    Nucifora, Frederick
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 342 - 342
  • [37] Predictors of cognitive performance in bipolar disorder: The role of educational degree and inflammatory markers
    Barbosa, Izabela Guimaraes
    Ferreira, Rodrigo de Almeida
    Rocha, Natalia Pessoa
    Mol, Giovana Carvalho
    Chiaccjio Leite, Flavia da Mata
    Bauer, Isabelle E.
    Teixeira, Antonio L.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2018, 106 : 31 - 37
  • [38] EVOLUTION OF INFLAMMATORY MARKERS IN PATIENTS WITH PROSTHETIC JOINT INFECTION TREATED WITH STIMULAN
    Dimofte, F.
    Serban, Cristina
    Tocu, G.
    Filip, Iulia
    Bezman, Laura
    Ciuntu, B. M.
    Abdulan, Irina Mihaela
    Guliciuc, M.
    Firescu, D.
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2024, 128 (03): : 507 - 516
  • [39] Longitudinal study of inflammatory markers and psychopathology in schizophrenia
    Feng, Tami
    McEvoy, Joseph P.
    Miller, Brian J.
    SCHIZOPHRENIA RESEARCH, 2020, 224 : 58 - 66
  • [40] Tobacco and cognitive performance in schizophrenia patients: the design of the COGNICO study
    Al-Halabi, Susana
    Fernandez-Artamendi, Sergio
    Diaz-Mesa, Eva M.
    Garcia-Alvarez, Leticia
    Florez, Gerardo
    Martinez Santamaria, Emilia
    Arrojo, Manuel
    Saiz, Pilar A.
    Garcia-Portilla, Paz
    Bobes, Julio
    ADICCIONES, 2017, 29 (01) : 6 - 12
12345